Skip to content
Peptigraph home

0.5 mg Retatrutide in Units: Syringe Chart

How many syringe units 0.5 mg of Retatrutide is, for every common vial size and water volume, with the math shown.

Medical review pendingGLP-1 / GIP / glucagon triple agonistUpdated
Amount
0.5 mg
At 5 mg/mL
10 units
e.g. 10 mg vial + 2 mL
At 10 mg/mL
5 units
e.g. 20 mg vial + 2 mL
Syringe
U-100
100 units = 1 mL

0.5 mg in units at common mixes

Units on a U-100 syringe (100 units = 1 mL) for a 0.5 mg amount, by vial size and water added. Concentration = vial mg ÷ mL of water; units = dose ÷ concentration × 100.

0.5 mg of Retatrutide in syringe units
VialWaterConcentrationUnits for 0.5 mgVolume
5 mg1 mL5 mg/mL10 u0.10 mL
5 mg2 mL2.5 mg/mL20 u0.20 mL
5 mg3 mL1.667 mg/mL30 u0.30 mL
10 mg1 mL10 mg/mL5 u0.05 mL
10 mg2 mL5 mg/mL10 u0.10 mL
10 mg3 mL3.333 mg/mL15 u0.15 mL
12 mg1 mL12 mg/mL4.2 u0.04 mL
12 mg2 mL6 mg/mL8.3 u0.08 mL
12 mg3 mL4 mg/mL12.5 u0.13 mL
15 mg1 mL15 mg/mL3.3 u0.03 mL
15 mg2 mL7.5 mg/mL6.7 u0.07 mL
15 mg3 mL5 mg/mL10 u0.10 mL
20 mg1 mL20 mg/mL2.5 u0.03 mL
20 mg2 mL10 mg/mL5 u0.05 mL
20 mg3 mL6.667 mg/mL7.5 u0.08 mL
24 mg1 mL24 mg/mL2.1 u0.02 mL
24 mg2 mL12 mg/mL4.2 u0.04 mL
24 mg3 mL8 mg/mL6.3 u0.06 mL

Calculator and full dosing table

Preset to 0.5 mg in a 10 mg vial. Change any value; the table below the result updates with it.

1Vial size
2Bacteriostatic water added
3Dose per injection
4Syringe (U-100)
Draw to
10units
= 0.1 mL on a 1 mL U-100 insulin syringe
10 mg vial2 mL water0.5 mg dose
Concentration
5 mg/mL
Doses per vial
20
Weeks (1 dose/wk)
20
Math only. It does not recommend a dose.

10 units (0.1 mL) on a 1 mL U-100 syringe: 0.5 mg from a 10 mg vial + 2 mL water (Retatrutide).

Dosing table for a 10 mg vial

Syringe units (U-100) for each dose, by how much bacteriostatic water you add.

Retatrutide: U-100 syringe units per dose for a 10 mg vial
Dose1 mL water2 mL water2.5 mL water3 mL water
0.5 mg51012.515
1 mg10202530
2 mg20405060
4 mg4080100120
6 mg60120150180
8 mg80160200240
10 mg100200250300

How the math works

Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.

10 mg ÷ 2 mL = 5 mg/mL
0.5 mg ÷ 5 mg/mL = 0.1 mL
0.1 mL × 100 = 10 units
10 units · 0.1 mL · 0.5 mg from 10 mg + 2 mL
Math only. The amounts in these tables are reference values for the arithmetic, not dose recommendations.

Where 0.5 mg shows up in retatrutide studies

The type 2 diabetes phase 2 trial compared once-weekly retatrutide maintenance doses of 0.5, 4, 8 and 12 mg with placebo and 1.5 mg dulaglutide, using 2 mg or 4 mg starting doses in some arms.[6]

In the type 2 diabetes phase 2 trial, HbA1c fell significantly more than with placebo in every retatrutide group except the 0.5 mg one.[6]

The 0.5 mg retatrutide group lost 3.19% of bodyweight at 36 weeks, against 3.00% on placebo and 2.02% on 1.5 mg dulaglutide.[6]

In the DXA substudy, total fat mass fell 4.9% from baseline on retatrutide 0.5 mg, compared with 4.5% on placebo.[7]

Gastrointestinal events were reported by 13% of the 47 participants in the 0.5 mg group and by 50% of the 24 in the 8 mg fast escalation group.[6]

How many units is 0.5 mg of retatrutide

0.5 mg of retatrutide drawn from vials mixed with 1 mL of water reads: 5 mg vial = 10 units; 10 mg vial = 5 units; 12 mg vial = 4.17† units; 15 mg vial = 3.33† units; 20 mg vial = 2.5† units; 24 mg vial = 2.08† units; 30 mg vial = 1.67† units; 36 mg vial = 1.39† units; 40 mg vial = 1.25† units; 50 mg vial = 1† units; 60 mg vial = 0.83† units. († marks a 0.5 mg reading under 5 units, hard to measure accurately; ‡ one over the 100 units a 1 mL U-100 syringe holds.)

Calculated from dose mg 0.5; vial sizes mg 5, 10, 12, 15, 20, 24, 30, 36, 40, 50, 60; water mL 1; u100 units per mL 100. Formula: units = doseMg / (vialMg / waterMl) x 100; flag units < 5 or > 100

0.5 mg of retatrutide drawn from vials mixed with 2 mL of water reads: 5 mg vial = 20 units; 10 mg vial = 10 units; 12 mg vial = 8.33 units; 15 mg vial = 6.67 units; 20 mg vial = 5 units; 24 mg vial = 4.17† units; 30 mg vial = 3.33† units; 36 mg vial = 2.78† units; 40 mg vial = 2.5† units; 50 mg vial = 2† units; 60 mg vial = 1.67† units. († marks a 0.5 mg reading under 5 units, hard to measure accurately; ‡ one over the 100 units a 1 mL U-100 syringe holds.)

Calculated from dose mg 0.5; vial sizes mg 5, 10, 12, 15, 20, 24, 30, 36, 40, 50, 60; water mL 2; u100 units per mL 100. Formula: units = doseMg / (vialMg / waterMl) x 100; flag units < 5 or > 100

0.5 mg of retatrutide drawn from vials mixed with 3 mL of water reads: 5 mg vial = 30 units; 10 mg vial = 15 units; 12 mg vial = 12.5 units; 15 mg vial = 10 units; 20 mg vial = 7.5 units; 24 mg vial = 6.25 units; 30 mg vial = 5 units; 36 mg vial = 4.17† units; 40 mg vial = 3.75† units; 50 mg vial = 3† units; 60 mg vial = 2.5† units. († marks a 0.5 mg reading under 5 units, hard to measure accurately; ‡ one over the 100 units a 1 mL U-100 syringe holds.)

Calculated from dose mg 0.5; vial sizes mg 5, 10, 12, 15, 20, 24, 30, 36, 40, 50, 60; water mL 3; u100 units per mL 100. Formula: units = doseMg / (vialMg / waterMl) x 100; flag units < 5 or > 100

One 0.5 mg injection a week uses up each vial size as follows: 5 mg vial = 10 doses; 10 mg vial = 20 doses; 12 mg vial = 24 doses; 15 mg vial = 30 doses; 20 mg vial = 40 doses; 24 mg vial = 48 doses; 30 mg vial = 60 doses; 36 mg vial = 72 doses; 40 mg vial = 80 doses; 50 mg vial = 100 doses; 60 mg vial = 120 doses.

Calculated from dose mg 0.5; vial sizes mg 5, 10, 12, 15, 20, 24, 30, 36, 40, 50, 60; injections per week 1. Formula: doses = floor(vialMg / doseMg); left = vialMg - doses x doseMg

Is 0.5 mg a labelled retatrutide amount

With 0 matching applications in Drugs@FDA there is no labelled retatrutide amount to compare 0.5 mg with.

Calculated from dose mg 0.5; drugs fda matches 0; source s2-legal/api.fda.gov/drugsfda-retatrutide.txt. Formula: labelled amounts available = 0

Common questions

How many units is 0.5 mg of Retatrutide?

It depends on the concentration. With a 10 mg vial and 2 mL of water (5 mg/mL), 0.5 mg is 10 units on a U-100 syringe. The table shows other mixes.

Is 0.5 mg a recommended dose of Retatrutide?

This page is math only. It converts an amount into syringe units and does not recommend a dose. See the dosage page for what studies used.

How many syringe units is 0.5 mg of retatrutide?

From a 10 mg vial mixed with 2 mL of water (5 mg/mL), 0.5 mg reads 10 units on a U-100 syringe; the figure changes with the vial size and water volume.

Calculated from dose mg 0.5; vial mg 10; water mL 2. Formula: units = doseMg / (vialMg / waterMl) x 100

More on Retatrutide

Sources

  1. 1Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial (Jastreboff AM et al.)New England Journal of Medicine · 2023PMID 37366315Accessed 2 Oct 2026
  2. 2Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (TRIUMPH-1; Jastreboff AM et al.)New England Journal of Medicine · 2026PMID 42814954Accessed 2 Oct 2026
  3. 3A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities (NCT04881760; arms and posted results)ClinicalTrials.gov (U.S. National Library of Medicine) · 2021clinicaltrials.govAccessed 2 Oct 2026
  4. 4Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  5. 5BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  6. 6Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.Lancet (London, England) · 2023PMID 37385280Accessed 2 Oct 2026
  7. 7Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial.The lancet. Diabetes & endocrinology · 2025PMID 40609566Accessed 2 Oct 2026

Found an error? Report a correction.